OA12120A - Transgenic insect. - Google Patents
Transgenic insect. Download PDFInfo
- Publication number
- OA12120A OA12120A OA1200200180A OA1200200180A OA12120A OA 12120 A OA12120 A OA 12120A OA 1200200180 A OA1200200180 A OA 1200200180A OA 1200200180 A OA1200200180 A OA 1200200180A OA 12120 A OA12120 A OA 12120A
- Authority
- OA
- OAPI
- Prior art keywords
- egg
- gene
- hardening
- mosquito
- anopheline
- Prior art date
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 33
- 230000009261 transgenic effect Effects 0.000 title description 3
- 241000255925 Diptera Species 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 26
- 244000045947 parasite Species 0.000 claims abstract description 15
- 210000001136 chorion Anatomy 0.000 claims abstract description 13
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 10
- 238000012239 gene modification Methods 0.000 claims abstract 2
- 230000005017 genetic modification Effects 0.000 claims abstract 2
- 235000013617 genetically modified food Nutrition 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 241001024304 Mino Species 0.000 claims description 12
- 239000003112 inhibitor Substances 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- CFOQGBUQTOGYKI-UHFFFAOYSA-N (4-nitrophenyl) 4-(diaminomethylideneamino)benzoate Chemical group C1=CC(N=C(N)N)=CC=C1C(=O)OC1=CC=C([N+]([O-])=O)C=C1 CFOQGBUQTOGYKI-UHFFFAOYSA-N 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 241000223960 Plasmodium falciparum Species 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 4
- 241000256056 Anopheles arabiensis Species 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 108010020764 Transposases Proteins 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 241001414900 Anopheles stephensi Species 0.000 claims description 2
- 230000003111 delayed effect Effects 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 206010021929 Infertility male Diseases 0.000 claims 1
- 208000007466 Male Infertility Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 abstract description 5
- 230000004048 modification Effects 0.000 abstract description 2
- 238000012986 modification Methods 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 description 17
- 210000002257 embryonic structure Anatomy 0.000 description 15
- 201000004792 malaria Diseases 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 8
- 239000013598 vector Substances 0.000 description 7
- 238000011161 development Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 238000010353 genetic engineering Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 241000256186 Anopheles <genus> Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 230000017105 transposition Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241001599018 Melanogaster Species 0.000 description 3
- 108010042474 Minos transposase Proteins 0.000 description 3
- 241000604961 Wolbachia Species 0.000 description 3
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 101150031823 HSP70 gene Proteins 0.000 description 2
- 241000224016 Plasmodium Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 229940125687 antiparasitic agent Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 101150052825 dnaK gene Proteins 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000017448 oviposition Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 241000256199 Anopheles freeborni Species 0.000 description 1
- 241000256182 Anopheles gambiae Species 0.000 description 1
- 101710120040 Antifungal peptide Proteins 0.000 description 1
- 241000872518 Aradus funestus Species 0.000 description 1
- 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 1
- 241000611432 Bactrocera tryoni Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241001249699 Capitata Species 0.000 description 1
- 108050004290 Cecropin Proteins 0.000 description 1
- 241000983417 Chrysomya bezziana Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 101710164770 Drosomycin Proteins 0.000 description 1
- 241000255597 Drosophila hydei Species 0.000 description 1
- 101000845857 Drosophila melanogaster Arylalkylamine N-acetyltransferase 1 Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101100379081 Emericella variicolor andC gene Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100120319 Escherichia coli fedA gene Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
- 241000405147 Hermes Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010057991 N-acetyldopamine desaturase Proteins 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000223801 Plasmodium knowlesi Species 0.000 description 1
- 241000223821 Plasmodium malariae Species 0.000 description 1
- 206010035501 Plasmodium malariae infection Diseases 0.000 description 1
- 241001505293 Plasmodium ovale Species 0.000 description 1
- 206010035502 Plasmodium ovale infection Diseases 0.000 description 1
- 241000223810 Plasmodium vivax Species 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 108010035075 Tyrosine decarboxylase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- -1 compound p-nitrophenyl-p'-guanidinobenzoate Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- LMBWSYZSUOEYSN-UHFFFAOYSA-N diethyldithiocarbamic acid Chemical compound CCN(CC)C(S)=S LMBWSYZSUOEYSN-UHFFFAOYSA-N 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 244000000011 human parasite Species 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000012222 in vivo site-directed mutagenesis Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 244000000040 protozoan parasite Species 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003046 sporozoite Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
- A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
- A01K67/0337—Genetically modified Arthropods
- A01K67/0339—Genetically modified insects, e.g. Drosophila melanogaster, medfly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929681.6A GB9929681D0 (en) | 1999-12-15 | 1999-12-15 | Transgenic insect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12120A true OA12120A (en) | 2006-05-05 |
Family
ID=10866392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200200180A OA12120A (en) | 1999-12-15 | 2000-12-13 | Transgenic insect. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030033622A1 (ja) |
| EP (1) | EP1242607A1 (ja) |
| JP (1) | JP2004500064A (ja) |
| CN (1) | CN1409766A (ja) |
| AP (1) | AP2002002514A0 (ja) |
| AU (1) | AU1871901A (ja) |
| BR (1) | BR0016398A (ja) |
| GB (1) | GB9929681D0 (ja) |
| MX (1) | MXPA02005960A (ja) |
| OA (1) | OA12120A (ja) |
| WO (1) | WO2001044483A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2661697A1 (en) | 2006-08-29 | 2008-03-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
| US8946460B2 (en) | 2012-06-15 | 2015-02-03 | Commonwealth Scientific And Industrial Research Organisation | Process for producing polyunsaturated fatty acids in an esterified form |
| SG11201604871VA (en) | 2013-12-18 | 2016-07-28 | Commw Scient Ind Res Org | Lipid comprising long chain polyunsaturated fatty acids |
| KR102527795B1 (ko) | 2014-06-27 | 2023-05-02 | 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 | 도코사펜타에노산을 포함하는 지질 |
| CN107466974B (zh) * | 2017-09-22 | 2019-12-20 | 广州威佰昆生物科技有限公司 | 一种用于显微注射的稻飞虱卵处理方法 |
| CN110024749B (zh) * | 2019-04-11 | 2021-11-16 | 遵义市林业科学研究所 | 一种金小蜂的保育方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5348874A (en) * | 1992-09-14 | 1994-09-20 | Institute For Molecular Biology And Biotechnology/Forth | Eukaryotic transposable element |
-
1999
- 1999-12-15 GB GBGB9929681.6A patent/GB9929681D0/en not_active Ceased
-
2000
- 2000-12-13 JP JP2001545560A patent/JP2004500064A/ja active Pending
- 2000-12-13 BR BR0016398-8A patent/BR0016398A/pt not_active IP Right Cessation
- 2000-12-13 AU AU18719/01A patent/AU1871901A/en not_active Abandoned
- 2000-12-13 US US10/148,772 patent/US20030033622A1/en not_active Abandoned
- 2000-12-13 WO PCT/GB2000/004771 patent/WO2001044483A1/en not_active Application Discontinuation
- 2000-12-13 EP EP00981484A patent/EP1242607A1/en not_active Withdrawn
- 2000-12-13 CN CN00817133A patent/CN1409766A/zh active Pending
- 2000-12-13 AP APAP/P/2002/002514A patent/AP2002002514A0/en unknown
- 2000-12-13 OA OA1200200180A patent/OA12120A/en unknown
-
2002
- 2002-06-14 MX MXPA02005960A patent/MXPA02005960A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1871901A (en) | 2001-06-25 |
| WO2001044483A1 (en) | 2001-06-21 |
| JP2004500064A (ja) | 2004-01-08 |
| EP1242607A1 (en) | 2002-09-25 |
| BR0016398A (pt) | 2002-12-03 |
| AP2002002514A0 (en) | 2002-06-30 |
| US20030033622A1 (en) | 2003-02-13 |
| GB9929681D0 (en) | 2000-02-09 |
| CN1409766A (zh) | 2003-04-09 |
| MXPA02005960A (es) | 2003-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Osta et al. | Innate immunity in the malaria vector Anopheles gambiae: comparative and functional genomics | |
| Page-McCaw et al. | Drosophila matrix metalloproteinases are required for tissue remodeling, but not embryonic development | |
| Kim et al. | Ectopic expression of a cecropin transgene in the human malaria vector mosquito Anopheles gambiae (Diptera: Culicidae): effects on susceptibility to Plasmodium | |
| EP2823047B1 (en) | Biocontrol | |
| CN112188834B (zh) | 自限性夜蛾 | |
| Boyle et al. | Gene manipulation in parasitic helminths | |
| OA12120A (en) | Transgenic insect. | |
| Meister et al. | The Plasmodium parasite—a ‘new’challenge for insect innate immunity | |
| Condon et al. | Germ‐line transformation of the Mexican fruit fly | |
| AU2019322100B2 (en) | Self-selecting sterile male arthropods | |
| Brown et al. | Toward silencing the burden of malaria: progress and prospects for RNAi-based approaches | |
| Atkinson et al. | What's buzzing? Mosquito genomics and transgenic mosquitoes | |
| WO2017132207A1 (en) | Use of medea elements for biocontrol of d. suzukii populations | |
| Cockburn et al. | Application of molecular genetics to insect control | |
| Sampath et al. | Transgenic mosquitoes to control vector borne diseases | |
| Alphey et al. | Genetic technologies to enhance the sterile insect technique (SIT) | |
| Pai | Development of PgSIT and Gynecider, Confinable Population Suppression Systems in Anopheles Gambiae | |
| Gross | Aedes aegypti Heat Shock 70 Genes and their Inducible Promoters | |
| Shrivastava et al. | Transgenic Mosquitoes Fight against Malaria: A Review | |
| Carballar-Lejarazú | Mosquito Gene Drives and the Malaria Eradication Agenda | |
| Chami | Réponse immunitaire de la drosophile à la guêpe endoparasitoïde Leptopilina boulardi: caractérisation d'une réaction de résistance | |
| Kim | Drosophila immune response to the endoparasitoid wasp Leptopilina boulardi: characterization of a resistance reaction | |
| Siriyasatien et al. | Genetically modified mosquitoes: A new strategy to control mosquito borne diseases | |
| WO2015040449A1 (en) | Culicinae mosquito tra-2 rnai, a method to genetically produce maleness populations | |
| McArthur | Generation and fitness of transgenic Anopheles gambiae and the impact of multiple feeding on anti-malarial properties of the vida3 transgene |